Navigating rough waters: reaching the zero-dose children of Manoka Island

23 Jan 2023

The Manoka Health District, a cluster of hard-to-reach islets in coastal Cameroon, is an immunisation blind spot: more than 90% of kids under two here have never had a single vaccine. Dr Nchinjoh plans to change that.

How has IFFIm made a difference for Gavi?

19 Dec 2022

Since 2006, IFFIm has contributed approximately US$ 5.2 billion to Gavi. IFFIm support has meant Gavi has been able to provide more life-saving vaccines, faster.

IFFIm funding contributes to health gains across Africa

19 Dec 2022

IFFIm provides funding for 15% of Gavi’s immunisation programmes across Africa.

HPV vaccines introduced in four new countries, aided by IFFIm funding

16 Dec 2022

IFFIm funding for Gavi’s ongoing HPV programmes is helping to prevent this deadly cancer in girls and women.

A new vaccine against typhoid rolls out in a flood-devastated province of Pakistan

04 Nov 2022

Armed with vials of Typhoid Conjugate Vaccine, health workers in Balochistan are doing what they can to protect children threatened by a pincer movement of global crises: antimicrobial resistance on the one hand and climate change on the other.

How the World Bank built trust in vaccine bonds

21 Oct 2022

Interview with Doris Herrera-Pol and Heike Reichelt.

Gavi Annual Progress Report: 2021 was “defining” for IFFIm

21 Oct 2022

From its founding in 2000 to the end of 2021, Gavi has helped to immunise a whole generation – over 981 million children – and prevented more than 16.2 million future deaths, helping to halve child mortality in 73 lower-income countries by the end of 2021. These are a few of the results published in Gavi’s 2021 Annual Progress Report.